Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.08.23	Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG… (RTTNews)
08.08.23	Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
01.08.23	Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023 (PR Newswire)
06.07.23	Novavax's Nuvaxovid Gets Full Marketing Authorization In EU To Prevent COVID-19 (RTTNews)
06.07.23	Novavax's Nuvaxovid™ Receives Full Marketing Authorization in the EU for the Prevention of COVID (PR Newswire)
15.06.23	Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall (PR Newswire)
15.06.23	Novavax Announces Adjournment of 2023 Annual Meeting of Stockholders to July 11, 2023 (PR Newswire)
05.06.23	Novavax Signs Deal With Bill & Melinda Gates Research Institute To Provide Matrix-M Adjuvant (RTTNews)
05.06.23	Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research (PR Newswire)
01.06.23	Novavax to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
26.05.23	Novavax Says Nuvaxovid Recommended For Full Marketing Authorization For COVID In EU (RTTNews)
26.05.23	Novavax's Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU (PR Newswire)
12.05.23	Singapore HSA Extends Interim Authorization To Novavax's COVID Vaccine For Adolescents (RTTNews)
12.05.23	Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore (PR Newswire)
09.05.23	Novavax Reports Positive Phase 2 Topline Results For Three Vaccine Candidates (RTTNews)
09.05.23	Novavax Sees FY23 Revenue Above Street, Plans 25% Job Cuts; Trial Result Positive; Stock Up (RTTNews)
09.05.23	Novavax Inc. Q1 Earnings Summary (RTTNews)
09.05.23	Novavax Reports First Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
09.05.23	Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses (PR Newswire)
04.05.23	Novavax to Participate in the BofA Securities 2023 Health Care Conference (PR Newswire)
02.05.23	Novavax to Host Conference Call to Discuss First Quarter 2023 Financial Results and Operational Highlights on May 9, 2023 (PR Newswire)
04.04.23	Novavax Grows Presence at World Vaccine Congress 2023 and 33rd European Congress of Clinical Microbiology & Infectious Diseases (PR Newswire)
06.03.23	Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference (PR Newswire)
02.03.23	Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
01.03.23	Pre-market Movers: RETA, ONCS, LION, NVAX, SRPT… (RTTNews)
28.02.23	Novavax Inc. Q4 Loss decreases, but misses estimates (RTTNews)
28.02.23	Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights (PR Newswire)
21.02.23	Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 28, 2023 (PR Newswire)
13.02.23	Novavax Extends Partnership With U.S. Health Dept. To Deliver 1.5 Mln Addl Doses Of NVX-CoV2373 (RTTNews)
13.02.23	U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine (PR Newswire)
25.01.23	Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
18.01.23	Novavax Up On Getting Approval For Its Booster Covid Vaccine For Adults In South Korea (RTTNews)
18.01.23	Novavax: Nuvaxovid Approved In South Korea As Booster For Active Immunization To Prevent COVID-19 (RTTNews)
18.01.23	Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster (PR Newswire)
09.01.23	Novavax Appoints John Jacobs To Succeed Stanley Erck As President And CEO (RTTNews)
09.01.23	Novavax Names John C. Jacobs as New President & Chief Executive Officer (PR Newswire)
30.12.22	Novavax To Initiate COVID-19 Phase 2 Influenza Combination, Stand Along Vaccine Trials (RTTNews)
30.12.22	Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates (PR Newswire)
28.12.22	Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2027 and $74.75 Million Public Offering of Common Stock (PR Newswire)
16.12.22	Novavax Prices Offering Of $150 Mln, 5% Senior Notes (RTTNews)
16.12.22	Novavax Announces Pricing of $65 Million Public Offering of Common Stock (PR Newswire)
16.12.22	Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes (PR Newswire)
14.12.22	Novavax Announces Proposed $125 Million Public Offering of Common Stock (PR Newswire)
14.12.22	Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes (PR Newswire)
07.12.22	Novavax : Canada Approves Nuvaxovid COVID-19 Vaccine For Use As Primary Series In Adolescents (RTTNews)
07.12.22	Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents (PR Newswire)
02.12.22	Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference (PR Newswire)
29.11.22	WHO Issues Updated Emergency Use Listing For Novavax's Nuvaxovid COVID-19 Vaccine (RTTNews)
29.11.22	World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 Vaccine as a Primary Series in Adolescents and as a Booster in Adults (PR Newswire)
18.11.22	Novavax: Health Canada Approves Nuvaxovid COVID-19 Vaccine As Adult Booster (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	51.86	1.25 %	K V
Swiss Life Hldg	773.00	1.18 %	K V
Lonza Grp	601.80	1.07 %	K V
UBS Group	30.43	0.83 %	K V
Zurich Insur Gr	567.80	0.78 %	K V
Logitech Intl	94.18	-0.19 %	K V
Givaudan	4’042.00	-0.42 %	K V
Sika	240.20	-0.78 %	K V
Swisscom	495.80	-0.80 %	K V
Sonova Hldg	299.00	-1.19 %	K V

mehr

17:58		Aufschläge in Europa: Zum Handelsende Gewinne im STOXX 50
17:58		Freundlicher Handel in London: FTSE 100 zum Handelsende im Aufwind
17:58		SLI-Handel aktuell: SLI zum Ende des Montagshandels auf grünem Terrain
17:58		Optimismus in Europa: Euro STOXX 50 schliesst in der Gewinnzone
17:58		SIX-Handel: SMI zum Handelsende im Aufwind
15:58		Freundlicher Handel in London: FTSE 100 am Nachmittag in der Gewinnzone
15:58		Handel in Europa: So performt der Euro STOXX 50 nachmittags
15:58		Pluszeichen in Europa: STOXX 50 nachmittags freundlich

17:58

Aufschläge in Europa: Zum Handelsende Gewinne im STOXX 50

17:58

Freundlicher Handel in London: FTSE 100 zum Handelsende im Aufwind

17:58

SLI-Handel aktuell: SLI zum Ende des Montagshandels auf grünem Terrain

17:58

Optimismus in Europa: Euro STOXX 50 schliesst in der Gewinnzone

17:58

SIX-Handel: SMI zum Handelsende im Aufwind

15:58

Freundlicher Handel in London: FTSE 100 am Nachmittag in der Gewinnzone